3SBio Priced At $331M In Go-Private Buyout Offer
Chinese biotech firm 3SBio Inc. is contemplating a buyout bid from a consortium led by its CEO that includes a China-focused private equity investor, it said Wednesday, in deal that would...To view the full article, register now.
Already a subscriber? Click here to view full article